SUPERIOR SVG: no touch saphenous harvesting to improve patency following coronary bypass grafting (a multi-Centre randomized control trial, NCT01047449)

[1]  A. Bras.  Endoscopic versus open vein-graft harvesting , 2018, Nature Reviews Cardiology.

[2]  M. Dashwood,et al.  No-touch vein grafts and the destiny of venous revascularization in coronary artery bypass grafting-a 25th anniversary perspective. , 2018, Annals of cardiothoracic surgery.

[3]  Volkmar Falk,et al.  2018 ESC/EACTS Guidelines on myocardial revascularization. , 2018, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[4]  Volkmar Falk,et al.  2018 ESC/EACTS Guidelines on myocardial revascularization. , 2018, European heart journal.

[5]  G. Angelini,et al.  Radial‐Artery or Saphenous‐Vein Grafts in Coronary‐Artery Bypass Surgery , 2018, The New England journal of medicine.

[6]  F. D’Ascenzo,et al.  Unmeasured Confounders in Observational Studies Comparing Bilateral Versus Single Internal Thoracic Artery for Coronary Artery Bypass Grafting: A Meta‐Analysis , 2018, Journal of the American Heart Association.

[7]  P. Haram,et al.  Pedicled Vein Grafts in Coronary Surgery: Perioperative Data From a Randomized Trial. , 2017, The Annals of thoracic surgery.

[8]  J. Choi,et al.  No-Touch Saphenous Vein Harvesting May Improve Further the Patency of Saphenous Vein Composite Grafts: Early Outcomes and 1-Year Angiographic Results. , 2017, The Annals of thoracic surgery.

[9]  D. Altman,et al.  Randomized Trial of Bilateral versus Single Internal-Thoracic-Artery Grafts. , 2016, The New England journal of medicine.

[10]  Ø. Pettersen,et al.  Pedicled Vein Grafts in Coronary Surgery Exhibit Reduced Intimal Hyperplasia at 6 Months. , 2016, Journal of the American College of Cardiology.

[11]  J. D. Mitchell,et al.  The Society of Thoracic Surgeons Clinical Practice Guidelines on Arterial Conduits for Coronary Artery Bypass Grafting. , 2016, The Annals of thoracic surgery.

[12]  Håkan Geijer,et al.  The no-touch saphenous vein for coronary artery bypass grafting maintains a patency, after 16 years, comparable to the left internal thoracic artery: A randomized trial. , 2015, The Journal of thoracic and cardiovascular surgery.

[13]  F. de Robertis,et al.  A Randomized Trial of External Stenting for Saphenous Vein Grafts in Coronary Artery Bypass Grafting. , 2015, The Annals of thoracic surgery.

[14]  S. Verma,et al.  Pedicled no-touch saphenous vein graft harvest limits vascular smooth muscle cell activation: the PATENT saphenous vein graft study. , 2014, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[15]  Jeroen J. Bax,et al.  Third universal definition of myocardial infarction , 2013, Nature Reviews Cardiology.

[16]  P. Calder,et al.  Omega-3 polyunsaturated fatty acids and cardiovascular disease , 2011 .

[17]  L. Bojö,et al.  Slower progression of atherosclerosis in vein grafts harvested with 'no touch' technique compared with conventional harvesting technique in coronary artery bypass grafting: an angiographic and intravascular ultrasound study. , 2010, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[18]  Fuad Moussa,et al.  The Graft Imaging to Improve Patency (GRIIP) clinical trial results. , 2010, The Journal of thoracic and cardiovascular surgery.

[19]  Antonio Colombo,et al.  Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. , 2009, The New England journal of medicine.

[20]  S. Shaw,et al.  Retaining perivascular tissue of human saphenous vein grafts protects against surgical and distension-induced damage and preserves endothelial nitric oxide synthase and nitric oxide synthase activity. , 2009, The Journal of thoracic and cardiovascular surgery.

[21]  R. Weiss,et al.  A meta-analysis of 3,773 patients treated with percutaneous coronary intervention or surgery for unprotected left main coronary artery stenosis. , 2009, JACC. Cardiovascular interventions.

[22]  R. Coppola,et al.  Arterial revascularization in primary coronary artery bypass grafting: Direct comparison of 4 strategies--results of the Stand-in-Y Mammary Study. , 2009, The Journal of thoracic and cardiovascular surgery.

[23]  J. Dyerberg,et al.  The composition of food consumed by Greenland Eskimos. , 2009, Acta medica Scandinavica.

[24]  S. Pocock,et al.  Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trials , 2009, The Lancet.

[25]  A. Newcomb,et al.  Choice of conduits for coronary artery bypass grafting: craft or science? , 2009, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[26]  John A McPherson,et al.  Routine intraoperative completion angiography after coronary artery bypass grafting and 1-stop hybrid revascularization results from a fully integrated hybrid catheterization laboratory/operating room. , 2009, Journal of the American College of Cardiology.

[27]  M. Dorgan,et al.  Effect of fish oil on arrhythmias and mortality: systematic review , 2008, BMJ : British Medical Journal.

[28]  M. Shackcloth,et al.  Attenuation of receptor-dependent and -independent vasoconstriction in the human radial artery. , 2008, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[29]  N. Desai,et al.  The Impact of Diabetic Status on Coronary Artery Bypass Graft Patency: Insights From the Radial Artery Patency Study , 2008, Circulation.

[30]  S. Damgaard,et al.  One-year results of total arterial revascularization vs. conventional coronary surgery: CARRPO trial. , 2008, European heart journal.

[31]  P. Serruys,et al.  Long-Term Safety and Efficacy of Percutaneous Coronary Intervention With Stenting and Coronary Artery Bypass Surgery for Multivessel Coronary Artery Disease: A Meta-Analysis With 5-Year Patient-Level Data From the ARTS, ERACI-II, MASS-II, and SoS Trials , 2008, Circulation.

[32]  D. Hu,et al.  A comparative study on in vitro and in vivo effects of topical vasodilators in human internal mammary, radial artery and great saphenous vein. , 2008, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[33]  B. Buxton,et al.  Effect of radial artery or saphenous vein conduit for the second graft on 6-year clinical outcome after coronary artery bypass grafting. Results of a randomised trial. , 2008, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[34]  N. Moat,et al.  Radial Artery Versus Saphenous Vein Patency Randomized Trial: Five-Year Angiographic Follow-Up , 2008, Circulation.

[35]  Sanjiv J. Shah,et al.  Intensive lipid-lowering with atorvastatin for secondary prevention in patients after coronary artery bypass surgery. , 2008, Journal of the American College of Cardiology.

[36]  S. Damgaard,et al.  Comparable three months' outcome of total arterial revascularization versus conventional coronary surgery: Copenhagen Arterial Revascularization Randomized Patency and Outcome trial. , 2008, The Journal of thoracic and cardiovascular surgery.

[37]  D. Newby,et al.  Dietary intervention with oil rich fish reduces platelet-monocyte aggregation in man. , 2008, Atherosclerosis.

[38]  R. Higgins,et al.  Drug-eluting stents vs. coronary-artery bypass grafting in multivessel coronary disease. , 2008, The New England journal of medicine.

[39]  Reza Ardehali,et al.  Systematic Review: The Comparative Effectiveness of Percutaneous Coronary Interventions and Coronary Artery Bypass Graft Surgery , 2007, Annals of Internal Medicine.

[40]  G. Angelini,et al.  A randomized trial of an external Dacron sheath for the prevention of vein graft disease: the Extent study. , 2007, The Journal of thoracic and cardiovascular surgery.

[41]  Y. Matsuzawa,et al.  Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis , 2007, The Lancet.

[42]  A. Kiss,et al.  Impact of Patient and Target-Vessel Characteristics on Arterial and Venous Bypass Graft Patency: Insight From a Randomized Trial , 2007, Circulation.

[43]  P. Kris-Etherton,et al.  Dietary alpha-linolenic acid inhibits proinflammatory cytokine production by peripheral blood mononuclear cells in hypercholesterolemic subjects. , 2007, The American journal of clinical nutrition.

[44]  G. Steinbeck,et al.  Highly Purified Omega-3 Fatty Acids for Secondary Prevention of Sudden Cardiac Death After Myocardial Infarction—Aims and Methods of the OMEGA-Study , 2006, Cardiovascular Drugs and Therapy.

[45]  Gideon Cohen,et al.  A randomized comparison of intraoperative indocyanine green angiography and transit-time flow measurement to detect technical errors in coronary bypass grafts. , 2006, The Journal of thoracic and cardiovascular surgery.

[46]  L. Bojö,et al.  Harvesting the saphenous vein with surrounding tissue for CABG provides long-term graft patency comparable to the left internal thoracic artery: results of a randomized longitudinal trial. , 2006, The Journal of thoracic and cardiovascular surgery.

[47]  D. Mozaffarian,et al.  Dietary fish and n-3 fatty acid intake and cardiac electrocardiographic parameters in humans. , 2006, Journal of the American College of Cardiology.

[48]  J. Tu,et al.  How many arterial grafts are enough? A population-based study of midterm outcomes. , 2006, The Journal of thoracic and cardiovascular surgery.

[49]  A. Sastre,et al.  Effects of omega-3 fatty acids on resting heart rate, heart rate recovery after exercise, and heart rate variability in men with healed myocardial infarctions and depressed ejection fractions. , 2006, The American journal of cardiology.

[50]  Prevent Iv Investigators.  Efficacy and safety of edifoligide, an E2F transcription factor decoy, for prevention of vein graft failure following coronary artery bypass graft surgery: PREVENT IV: a randomized controlled trial. , 2005 .

[51]  Gideon Cohen,et al.  Improving the quality of coronary bypass surgery with intraoperative angiography: validation of a new technique. , 2005, Journal of the American College of Cardiology.

[52]  D. Abraham,et al.  Effect of vein graft harvesting on endothelial nitric oxide synthase and nitric oxide production. , 2005, The Annals of thoracic surgery.

[53]  C. Pandozi,et al.  N-3 Fatty acids for the prevention of atrial fibrillation after coronary artery bypass surgery: a randomized, controlled trial. , 2005, Journal of the American College of Cardiology.

[54]  A. Geelen,et al.  Effects of n-3 fatty acids from fish on premature ventricular complexes and heart rate in humans. , 2005, The American journal of clinical nutrition.

[55]  C David Naylor,et al.  A randomized comparison of radial-artery and saphenous-vein coronary bypass grafts. , 2004, The New England journal of medicine.

[56]  T. Athanasiou,et al.  Are wound healing disturbances and length of hospital stay reduced with minimally invasive vein harvest? A meta-analysis. , 2004, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[57]  P. Serruys,et al.  Sirolimus eluting stent implantation for patients with multivessel disease: rationale for the arterial revascularisation therapies study part II (ARTS II) , 2004, Heart.

[58]  P. Calder.  n-3 Fatty acids and cardiovascular disease: evidence explained and mechanisms explored. , 2004, Clinical science.

[59]  Gregg W Stone,et al.  One-Year Clinical Results With the Slow-Release, Polymer-Based, Paclitaxel-Eluting TAXUS Stent: The TAXUS-IV Trial , 2004, Circulation.

[60]  M. Metra,et al.  Total Arterial Myocardial Revascularization With Composite Grafts Improves Results of Coronary Surgery in Elderly: A Prospective Randomized Comparison With Conventional Coronary Artery Bypass Surgery , 2003, Circulation.

[61]  P. Calder,et al.  Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomised controlled trial , 2003, The Lancet.

[62]  P. Serruys,et al.  Two-Year Angiographic and Intravascular Ultrasound Follow-Up After Implantation of Sirolimus-Eluting Stents in Human Coronary Arteries , 2003, Circulation.

[63]  Lawrence J Appel,et al.  Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[64]  M. Santini,et al.  Early Protection Against Sudden Death by n-3 Polyunsaturated Fatty Acids After Myocardial Infarction: Time-Course Analysis of the Results of the Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto Miocardico (GISSI)-Prevenzione , 2002, Circulation.

[65]  M. Dashwood,et al.  Improved patency in vein grafts harvested with surrounding tissue: results of a randomized study using three harvesting techniques. , 2002, The Annals of thoracic surgery.

[66]  Douglas G Altman,et al.  Effect of arterial revascularisation on survival: a systematic review of studies comparing bilateral and single internal mammary arteries , 2001, The Lancet.

[67]  N L Geller,et al.  Prognostic factors for atherosclerosis progression in saphenous vein grafts: the postcoronary artery bypass graft (Post-CABG) trial. Post-CABG Trial Investigators. , 2000, Journal of the American College of Cardiology.

[68]  GISSI-Prevenzione Investigators,et al.  Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial , 1999, The Lancet.

[69]  F. Loop,et al.  Two internal thoracic artery grafts are better than one. , 1999, The Journal of thoracic and cardiovascular surgery.

[70]  S. Wan,et al.  Routine intraoperative angiography improves the early patency of coronary grafts performed on the beating heart. , 1999, Chest.

[71]  Post Coronary Artery Bypass Graft Trial Investigators.  The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts. , 1997, The New England journal of medicine.

[72]  W J Keon,et al.  Coronary bypass graft fate and patient outcome: angiographic follow-up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25 years. , 1996, Journal of the American College of Cardiology.

[73]  A. Carpentier,et al.  Revival of the radial artery for coronary artery bypass grafting. , 1992, The Annals of thoracic surgery.

[74]  R. Califf,et al.  Starting aspirin therapy after operation. , 1992, Circulation.

[75]  J. Copeland,et al.  Starting Aspirin Therapy After Operation: Effects on Early Graft Patency , 1991, Circulation.

[76]  P. Elwood,et al.  EFFECTS OF CHANGES IN FAT, FISH, AND FIBRE INTAKES ON DEATH AND MYOCARDIAL REINFARCTION: DIET AND REINFARCTION TRIAL (DART) , 1989, The Lancet.

[77]  W. C. Sheldon,et al.  Influence of the internal-mammary-artery graft on 10-year survival and other cardiac events. , 1986, The New England journal of medicine.

[78]  F. Loop,et al.  Long-term (5 to 12 years) serial studies of internal mammary artery and saphenous vein coronary bypass grafts. , 1985, The Journal of thoracic and cardiovascular surgery.

[79]  M. Bourassa,et al.  Atherosclerosis and late closure of aortocoronary saphenous vein grafts: sequential angiographic studies at 2 weeks, 1 year, 5 to 7 years, and 10 to 12 years after surgery. , 1983, Circulation.

[80]  Maarten L. Simoons,et al.  The third universal definition of myocardial infarction , 2013 .

[81]  L. Norgren,et al.  The "no-touch" harvesting technique for vein grafts in coronary artery bypass surgery preserves an intact vasa vasorum. , 2011, The Journal of thoracic and cardiovascular surgery.

[82]  R. Habib,et al.  Late results of conventional versus all-arterial revascularization based on internal thoracic and radial artery grafting. , 2009, The Annals of thoracic surgery.

[83]  N. Desai,et al.  Radial artery angiographic string sign: clinical consequences and the role of pharmacologic therapy. , 2006, The Annals of thoracic surgery.

[84]  B. Gersh.  Long-term Outcomes of Coronary-Artery Bypass Grafting Versus Stent Implantation , 2006 .

[85]  M. Metra,et al.  Left internal thoracic artery-radial artery composite grafts as the technique of choice for myocardial revascularization in elderly patients: a prospective randomized evaluation. , 2004, The Journal of thoracic and cardiovascular surgery.

[86]  P. Cerrito,et al.  A review of transit-time flow measurement for assessing graft patency. , 1999, The heart surgery forum.

[87]  Risk factors for deep sternal wound infection after sternotomy: a prospective, multicenter study. , 1996, The Journal of thoracic and cardiovascular surgery.

[88]  K. Grønseth,et al.  Effect of dietary supplementation with n-3 fatty acids on coronary artery bypass graft patency. , 1996, The American journal of cardiology.

[89]  C. Naylor,et al.  Optimal antithrombotic therapy following aortocoronary bypass: a meta-analysis. , 1993, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[90]  L. Tavazzi,et al.  ect of n-3 polyunsaturated fatty acids in patients with chronic heart failure ( the GISSI-HF trial ) : a randomised , double-blind , placebo-controlled trial , 1980 .